Published in Medical Letter on the CDC and FDA, February 16th, 2003
"A high index of suspicion, detailed investigation of the travel and exposure history of the patient, and a basic understanding of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.